v3.26.1
EQUITY-BASED COMPENSATION (Tables)
 6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Payment Arrangement, Expensed and Capitalized, Amount The Company’s equity-based compensation expense, included within selling, general and administrative expenses in the condensed consolidated statements of operations and comprehensive income (loss), was as follows (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
Restricted Stock$5,742 $9,921 $12,004 $21,106 
SARs— 127 — 253 
Total$5,742 $10,048 $12,004 $21,359 
Schedule of Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity A summary of Restricted Stock activity during the six months ended June 30, 2026 is as follows:
Restricted Stock
Weighted Average Grant Date
Fair Value Per Share
Outstanding as of December 31, 2025247,022$505.85 
Granted(1)
342,376$100.75 
Forfeited(24,594)$515.91 
Vested and issued(48,653)$617.49 
Outstanding as of June 30, 2026516,151$226.13 
Vested and deferred as of June 30, 202619,389$457.71 
(1)Performance-based RSUs were granted at target value for 2026.
Schedule of Share-Based Payment Award, Restricted Stock Valuation Assumptions
The weighted average of significant inputs and resulting grant date fair values for market-based award grants were as follows:
Three Months Ended June 30,
20262025
Risk-free interest rate3.4 %4.2 %
Expected volatility59.4 %40.6 %
Simulation term (in years)2.92 years2.99 years
Weighted average grant date fair value$110.74$417.46
Schedule of Share-Based Payment Arrangement, Stock Appreciation Right, Activity A summary of SARs activity during the six months ended June 30, 2026 is as follows:
Stock Appreciation Rights
Weighted Average Exercise Price
Weighted Average Grant Date
Fair Value
Aggregate Intrinsic Value
(in thousands)
Weighted Average
Remaining Contractual Term
(in years)
Outstanding as of December 31, 202516,616$1,225.32 $309.52 $— 3.5
Outstanding as of June 30, 202616,616$1,225.32 $309.52 $— 3.0
Exercisable as of June 30, 202616,616$1,225.32 $309.52 $— 3.0